Aqtual

Aqtual is a San Francisco-based diagnostics company founded in 2020 that aims to revolutionize chronic disease and oncology management. The company's mission is to bridge the gap between research and clinical practice by developing highly accurate blood tests for disease detection, monitoring, and patient stratification. Its core technology analyzes cell-free DNA to derive epigenetics, gene regulation, and transcriptomic insights from a single blood draw.